Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD. Milstein M, et al. Among authors: davies g. BMC Infect Dis. 2016 Aug 27;16(1):453. doi: 10.1186/s12879-016-1790-x. BMC Infect Dis. 2016. PMID: 27567500 Free PMC article.
Isoniazid activity is terminated by bacterial persistence.
Mitchison DA, Jindani A, Davies GR, Sirgel F. Mitchison DA, et al. J Infect Dis. 2007 Jun 15;195(12):1871-2; author reply 1872-3. doi: 10.1086/518046. J Infect Dis. 2007. PMID: 17492605 No abstract available.
The chemotherapy of tuberculosis: past, present and future.
Mitchison D, Davies G. Mitchison D, et al. Among authors: davies g. Int J Tuberc Lung Dis. 2012 Jun;16(6):724-32. doi: 10.5588/ijtld.12.0083. Int J Tuberc Lung Dis. 2012. PMID: 22613684 Free PMC article. Review.
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P. Furin J, et al. Among authors: davies g. Int J Tuberc Lung Dis. 2016 Mar;20(3):290-4. doi: 10.5588/ijtld.15.0490. Int J Tuberc Lung Dis. 2016. PMID: 27046707 Free PMC article.
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G. Peloquin CA, et al. Among authors: davies g. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00038-17. doi: 10.1128/AAC.00038-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28559269 Free PMC article. Clinical Trial.
3,575 results